In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models

Cancer Immunology Research · Published 2026-07-08 · DOI 10.1158/2326-6066.cir-25-1475

Authors (15)

Trishna Debnath, Won Jong Jin, Ravi B. Patel, Peter M. Carlson, Md Mahfuzur Rahman, Tracy J. Berg, Caroline P. Kerr, Rene Welch Schwartz, Yujuan Wang, Meredith Hyun, Irene M. Ong, Jamey P. Weichert, Reinier Hernandez, Paul M. Sondel, Zachary S. Morris

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Debnath, T., Jin, W., Patel, R., et al. (2026). In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-25-1475

Related articles